Cullinan Therapeutics: Thesis Strengthening For This T-Cell Engager Specialist
Source: SeekingAlpha
2026-02-23 17:39:15 ET
Shares of Cullinan Therapeutics ( CGEM ) have risen by 31% year-to-date, yet are down 70% over the past five years....
Read the full article on Seeking Alpha
For further details see:
Cullinan Therapeutics: Thesis Strengthening For This T-Cell Engager Specialist
Cullinan Oncology Inc.
NASDAQ: CGEM
CGEM Trading
-4.48% G/L:
$13 Last:
409,370 Volume:
$12.70 Open:
CGEM Latest News
CGEM Stock Data
$736,680,950
44,578,945
0.22%
39
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
